Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
Clinical trial NCT05833438 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05833438
- Sponsor
- University of Leipzig
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2025-11-16
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.